Not known Factual Statements About pentobarbital sodium price
Not known Factual Statements About pentobarbital sodium price
Blog Article
B: Could possibly be satisfactory. Either animal scientific studies clearly show no threat but human scientific tests not out there or animal scientific tests confirmed minimal hazards and human scientific tests done and confirmed no threat.
pentobarbital will lessen the extent or effect of theophylline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will lower the extent or influence of lorlatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lessen the level or impact of alprazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will minimize the extent or effect of estradiol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
Contraindicated. Coadministration of doravirine with a strong CYP3A inducer might lessen doravirine plasma concentrations and/or effects. Prospective for lack of virologic reaction and achievable resistance to doravirine.
pentobarbital will minimize the extent or result of estrogens conjugated artificial by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will decrease the level or influence of methadone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will minimize the extent or result of budesonide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will reduce the extent or influence of mavacamten by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
fentanyl transdermal and pentobarbital both raise sedation. Avoid or Use Alternate Drug. Restrict use to individuals for whom choice procedure possibilities are insufficient
pentobarbital will lower the level or outcome of ondansetron by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe. No dosage adjustment for ondansetron is suggested for patients on these drugs.
pentobarbital decreases effects of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Intently. Coadministration of CYP3A4 inducers may possibly decrease sufentanil concentrations and efficacy, potentially precipitating withdrawal syndrome in people which have designed Actual physical dependence to more info sufentanil. Discontinuation of concomitantly utilised CYP3A4 inducers may enhance sufentanil plasma focus.
pentobarbital will decrease the extent or result of alosetron by affecting hepatic enzyme CYP2C9/ten metabolism. Slight/Significance Unknown.